Resurgent Financial Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $641K | Buy |
822
+98
| +14% | +$76.4K | 0.35% | 78 |
|
|
2025
Q1 | $598K | Buy |
724
+26
| +4% | +$21.5K | 0.36% | 78 |
|
|
2024
Q4 | $539K | Buy |
698
+96
| +16% | +$74.1K | 0.32% | 93 |
|
|
2024
Q3 | $533K | Buy |
602
+8
| +1% | +$7.09K | 0.31% | 91 |
|
|
2024
Q2 | $538K | Sell |
594
-66
| -10% | -$59.8K | 0.33% | 90 |
|
|
2024
Q1 | $513K | Buy |
660
+69
| +12% | +$53.7K | 0.27% | 104 |
|
|
2023
Q4 | $345K | Buy |
591
+5
| +0.9% | +$2.92K | 0.21% | 121 |
|
|
2023
Q3 | $315K | Buy |
586
+21
| +4% | +$11.3K | 0.21% | 106 |
|
|
2023
Q2 | $265K | Buy |
565
+40
| +8% | +$18.8K | 0.18% | 116 |
|
|
2023
Q1 | $180K | Sell |
525
-173
| -25% | -$59.4K | 0.12% | 157 |
|
|
2022
Q4 | $255K | Sell |
698
-40
| -5% | -$14.6K | 0.13% | 159 |
|
|
2022
Q3 | $239K | Buy |
+738
| New | +$239K | 0.16% | 156 |
|